Top 5 Value Stocks To Buy For 2019

After Coca-Cola (NYSE:KO) reported its second-quarter results late last month, senior leadership shared some important details of the progress its making on several fronts during its investor call.

Here are the biggest takeaways for long-term shareholders.

Diet Coke’s new flavors are a big hit. Image source: Coca-Cola.

Share gains

Let me start by saying and underlining that we’re winning in a dynamic and vibrant industry. The global beverage industry is growing faster than last year, driven by better results in the emerging and developing markets, and also the sparkling soft drink category. We’re gaining value share as we execute on the strategies we laid out for you in early 2017, and importantly, our operating performance is accelerating as a result. — CEO James Quincey

Top 5 Value Stocks To Buy For 2019: Simulations Plus, Inc.(SLP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Simulations Plus, Inc. (NASDAQ:SLP) Director Walter S. Woltosz sold 18,500 shares of the business’s stock in a transaction dated Thursday, September 27th. The shares were sold at an average price of $19.92, for a total value of $368,520.00. Following the completion of the transaction, the director now directly owns 5,417,908 shares of the company’s stock, valued at $107,924,727.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

  • [By Stephan Byrd]

    Mattersight (NASDAQ: MATR) and Simulations Plus (NASDAQ:SLP) are both small-cap computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, risk, institutional ownership, earnings and analyst recommendations.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Simulations Plus (SLP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Simulations Plus (NASDAQ: SLP) and NetScout Systems (NASDAQ:NTCT) are both computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership and analyst recommendations.

  • [By Shane Hupp]

    News headlines about Simulations Plus (NASDAQ:SLP) have trended somewhat positive on Tuesday, Accern reports. The research firm rates the sentiment of media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Simulations Plus earned a media sentiment score of 0.15 on Accern’s scale. Accern also assigned media headlines about the technology company an impact score of 45.8174942937785 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

  • [By Stephan Byrd]

    Simulations Plus (NASDAQ:SLP) and CSRA (NYSE:CSRA) are both computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, dividends, analyst recommendations, earnings, institutional ownership, risk and valuation.

Top 5 Value Stocks To Buy For 2019: Tiptree Financial Inc.(TIPT)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Tiptree Inc (NASDAQ:TIPT) CFO Sandra Bell sold 8,682 shares of the business’s stock in a transaction on Monday, September 17th. The shares were sold at an average price of $6.55, for a total transaction of $56,867.10. Following the completion of the sale, the chief financial officer now directly owns 41,881 shares of the company’s stock, valued at $274,320.55. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

  • [By Tim Melvin]

    This week, I ran across Tiptree Inc. (Nasdaq: TIPT) on the list of stocks with the highest VQScores. Tiptree fits most of my parameters as well so I spent a little time digging into the company further.

  • [By Joseph Griffin]

    TRADEMARK VIOLATION WARNING: “Tiptree (TIPT) Raised to C at TheStreet” was posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this piece of content on another site, it was stolen and reposted in violation of United States and international copyright & trademark law. The original version of this piece of content can be accessed at www.tickerreport.com/banking-finance/3350618/tiptree-tipt-raised-to-c-at-thestreet.html.

Top 5 Value Stocks To Buy For 2019: Era Group, Inc.(ERA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Co-Diagnostics, Inc. (NASDAQ: CODX) fell 11.6 percent to $3.13 in pre-market trading after surging 118.52 percent on Tuesday.
    Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) shares fell 6.5 percent to $2.60 in pre-market trading after rising 1.09 percent on Tuesday.
    T2 Biosystems, Inc. (NASDAQ: TTOO) fell 6 percent to $7.58 in pre-market trading after dropping 9.13 percent on Tuesday.
    Era Group Inc. (NYSE: ERA) fell 4.8 percent to $12.30 in the pre-market trading session.
    DSW Inc. (NYSE: DSW) shares fell 4.1 percent to $25.00 in pre-market trading after reporting Q1 results.
    ZTO Express (Cayman) Inc. (NYSE: ZTO) shares fell 2.7 percent to $20.25 in pre-market trading after rising 7.88 percent on Tuesday.
    Daktronics, Inc. (NASDAQ: DAKT) fell 2.5 percent to $9.81 in pre-market trading. Daktronics is expected to release quarterly earnings today.
    AngloGold Ashanti Limited (NYSE: AU) fell 2.2 percent to $8.28 in pre-market trading

  • [By Logan Wallace]

    Media stories about Era Group (NYSE:ERA) have been trending somewhat positive recently, Accern reports. Accern ranks the sentiment of media coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Era Group earned a media sentiment score of 0.15 on Accern’s scale. Accern also assigned headlines about the transportation company an impact score of 47.38255838638 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

  • [By Logan Wallace]

    ERA (CURRENCY:ERA) traded down 12.1% against the US dollar during the 1 day period ending at 22:00 PM ET on June 30th. One ERA coin can currently be purchased for about $0.0073 or 0.00000115 BTC on popular exchanges including CoinExchange and Cryptohub. Over the last week, ERA has traded 1.6% lower against the US dollar. ERA has a market capitalization of $0.00 and approximately $299.00 worth of ERA was traded on exchanges in the last day.

  • [By Logan Wallace]

    Era Group (NYSE:ERA) was upgraded by research analysts at ValuEngine from a “hold” rating to a “buy” rating in a report released on Saturday.

Top 5 Value Stocks To Buy For 2019: Flagstar Bancorp, Inc.(FBC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Millennium Management LLC lessened its position in shares of Flagstar Bancorp Inc (NYSE:FBC) by 87.9% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 6,422 shares of the savings and loans company’s stock after selling 46,458 shares during the quarter. Millennium Management LLC’s holdings in Flagstar Bancorp were worth $227,000 at the end of the most recent reporting period.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Flagstar Bancorp (FBC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Jordan Wathen]

    In a win-win deal, deposit-starved Flagstar Bancorp (NYSE:FBC) will take Wells Fargo’s underperforming branches off of its hands — and pay a premium to do it. 

  • [By Joseph Griffin]

    EJF Capital LLC lowered its stake in shares of Flagstar Bancorp Inc (NYSE:FBC) by 14.1% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,056,997 shares of the savings and loans company’s stock after selling 173,003 shares during the quarter. Flagstar Bancorp makes up approximately 3.0% of EJF Capital LLC’s holdings, making the stock its 8th biggest holding. EJF Capital LLC’s holdings in Flagstar Bancorp were worth $37,418,000 as of its most recent SEC filing.

  • [By Joseph Griffin]

    Stephens reiterated their hold rating on shares of Flagstar Bancorp (NYSE:FBC) in a research report sent to investors on Monday morning.

    Several other brokerages have also weighed in on FBC. B. Riley reissued a buy rating on shares of Flagstar Bancorp in a report on Friday, March 2nd. Sandler O’Neill raised Flagstar Bancorp from a hold rating to a buy rating in a report on Thursday, June 7th. Boenning Scattergood reissued a buy rating and issued a $41.00 price objective on shares of Flagstar Bancorp in a report on Wednesday, June 6th. Zacks Investment Research lowered Flagstar Bancorp from a strong-buy rating to a hold rating in a report on Tuesday, February 13th. Finally, Wedbush decreased their price objective on Flagstar Bancorp from $45.00 to $40.00 and set an outperform rating for the company in a report on Thursday, April 12th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and eight have issued a buy rating to the stock. The company currently has a consensus rating of Buy and an average price target of $40.43.

Top 5 Value Stocks To Buy For 2019: Jazz Pharmaceuticals Inc.(JAZZ)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Jazz Pharmaceuticals (JAZZ)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Keybank National Association OH purchased a new position in shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 2,808 shares of the specialty pharmaceutical company’s stock, valued at approximately $484,000.

  • [By Logan Wallace]

    Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)’s share price hit a new 52-week high and low during mid-day trading on Tuesday . The company traded as low as $173.93 and last traded at $172.72, with a volume of 22282 shares. The stock had previously closed at $172.50.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Jazz Pharmaceuticals (JAZZ)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Leave a Reply

Your email address will not be published. Required fields are marked *